Cargando…

Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics

Trial enrichment using gut microbiota derived biomarkers by high-risk individuals can improve the feasibility of randomized controlled trials for prevention of Clostridioides difficile infection (CDI). Here, we report in a prospective observational cohort study the incidence of CDI and assess potent...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Werkhoven, Cornelis H., Ducher, Annie, Berkell, Matilda, Mysara, Mohamed, Lammens, Christine, Torre-Cisneros, Julian, Rodríguez-Baño, Jesús, Herghea, Delia, Cornely, Oliver A., Biehl, Lena M., Bernard, Louis, Dominguez-Luzon, M. Angeles, Maraki, Sofia, Barraud, Olivier, Nica, Maria, Jazmati, Nathalie, Sablier-Gallis, Frederique, de Gunzburg, Jean, Mentré, France, Malhotra-Kumar, Surbhi, Bonten, Marc J. M., Vehreschild, Maria J. G. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046770/ https://www.ncbi.nlm.nih.gov/pubmed/33854064 http://dx.doi.org/10.1038/s41467-021-22269-y

Ejemplares similares

Microbiota-based markers predictive of development of Clostridioides difficile infection
por: Berkell, Matilda, et al.
Publicado: (2021)

LB-5. DAV132 Protects Intestinal Microbiota of Patients Treated with Quinolones, a European Phase II Randomized Controlled Trial (SHIELD)
por: Ducher, Annie, et al.
Publicado: (2020)

An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones
por: Vehreschild, Maria J. G. T., et al.
Publicado: (2022)

Change in Bacterial Diversity of Fecal Microbiota Drives Mortality in a Hamster Model of Antibiotic-induced Clostridium difficile Colitis
por: Burdet, Charles, et al.
Publicado: (2017)

Clostridioides difficile infections in the intensive care unit: a monocentric cohort study
por: Aguilar, Rebeca Cruz, et al.
Publicado: (2020)

Protection of the Human Gut Microbiome From Antibiotics
por: de Gunzburg, Jean, et al.
Publicado: (2018)

Microbiological Characterization and Clinical Outcomes After Extended-Pulsed Fidaxomicin Treatment for Clostridioides difficile Infection in the EXTEND Study
por: Wilcox, Mark H, et al.
Publicado: (2019)

Host Immunity Influences the Composition of Murine Gut Microbiota
por: Van averbeke, Vincent, et al.
Publicado: (2022)

Longitudinal variability in the urinary microbiota of healthy premenopausal women and the relation to neighboring microbial communities: A pilot study
por: Biehl, Lena M., et al.
Publicado: (2022)

1568. Implementation of a Standard Diet Regimen for Neutropenic High-Risk Cancer Patients: Effects on Incidence of Infections, Foodborne Diseases, and Outcome
por: Jakob, Carolin, et al.
Publicado: (2018)

Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022
por: Van Heirstraeten, Liesbet, et al.
Publicado: (2022)

Trends in the epidemiology of Clostridioides difficile infection in Germany
por: Vehreschild, Maria Johanna Gobertina Tetuanui, et al.
Publicado: (2023)

Mathematical Modeling of Bacterial Kinetics to Predict the Impact of Antibiotic Colonic Exposure and Treatment Duration on the Amount of Resistant Enterobacteria Excreted
por: Nguyen, Thu Thuy, et al.
Publicado: (2014)

The dynamic transcriptome during maturation of biofilms formed by methicillin-resistant Staphylococcus aureus
por: Vlaeminck, Jelle, et al.
Publicado: (2022)

Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls
por: van Werkhoven, C. H., et al.
Publicado: (2018)

221. Assessment and Proposed Revision of Clinical Trial Clostridioides difficile Infection Clinical Response and Outcomes Definitions
por: Gonzales-Luna, Anne J, et al.
Publicado: (2022)

2389. Assessing the Time Course of Proton Pump Inhibitor Use and Clostridioides difficile Infection
por: Panagos, Katherine, et al.
Publicado: (2019)

Evaluation of GeneXpert PA assay compared to genomic and (semi-)quantitative culture methods for direct detection of Pseudomonas aeruginosa in endotracheal aspirates
por: van der Schalk, Thomas Ewout, et al.
Publicado: (2021)

2430. Comorbidity and Severity of Illness Risk Adjustment for Hospital-Onset Clostridioides difficile Infection
por: Cabral, Stephanie, et al.
Publicado: (2019)

2119. Matched-Paired Analysis of Patients Treated for Invasive Mucormycosis—Standard Treatment vs. Posaconazole New Formulations (MoveOn)
por: Salmanton-Garcia, Jon, et al.
Publicado: (2019)

Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy
por: Ballo, Olivier, et al.
Publicado: (2020)

730. Severity Of Clostridioides difficile Infection Based On Toxin Analysis, Acid Suppressant Medications and Antibiotics
por: Krishnan, Gayathri, et al.
Publicado: (2020)

2077. Assessment of the Clinical Impact of Rapid Identification with Same-Day Phenotypic Antimicrobial Susceptibility Testing (Accelerate Pheno™ System) on the Management of Bloodstream Infections in Adult Patients with Antibiotic Stewardship Intervention: A Retrospective Observational Study
por: Ehren, Kathrin, et al.
Publicado: (2018)

BacPipe: A Rapid, User-Friendly Whole-Genome Sequencing Pipeline for Clinical Diagnostic Bacteriology
por: Xavier, Basil B., et al.
Publicado: (2019)

412. Clinical and Pharmacoeconomic Evaluation of Antifungal Prophylaxis With Continuous Micafungin Compared to Posaconazole With Micafungin Bridging in Patients Undergoing Allogeneic Stem Cell Transplantation: A 6-Year Cohort Analysis
por: Heimann, Sebastian M, et al.
Publicado: (2018)

Epidemiology of Surgical Site Infections With Staphylococcus aureus in Europe: Protocol for a Retrospective, Multicenter Study
por: Mellinghoff, Sibylle C, et al.
Publicado: (2018)

Metadata Correction: Epidemiology of Surgical Site Infections With Staphylococcus aureus in Europe: Protocol for a Retrospective, Multicenter Study
por: Mellinghoff, Sibylle C, et al.
Publicado: (2019)

Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer
por: Cornely, Oliver A, et al.
Publicado: (2020)

2046. FungiScope™: News on the Global Emerging Fungal Infection Registry
por: Seidel, Danila, et al.
Publicado: (2018)

Comparison of stool samples and rectal swabs with and without pre-enrichment for the detection of third-generation cephalosporin-resistant Enterobacterales (3GCREB)
por: Jazmati, Tarek, et al.
Publicado: (2021)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

2433. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridioides difficile Infection in Critically Ill Patients
por: Vega, Ana D, et al.
Publicado: (2019)

793. Expert Panel Consensus Ranking of Comorbid Conditions Causally Related to Clostridioides difficile Infection
por: Goodman, Katherine E, et al.
Publicado: (2020)

Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis
por: ten Doesschate, Thijs, et al.
Publicado: (2019)

Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
por: Schmidt-Hieber, M., et al.
Publicado: (2017)

An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales
por: Deelen, J W Timotëus, et al.
Publicado: (2020)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
por: Gupta, Akshita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fi6q01lmp1bka8egvda7msa1ad